Baxter International (BAX) – Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Baxter International (NYSE: BAX) recently:

• 11/9/2026 – Baxter International had its price target raised by Barclays from $20.00 to $23.00. They now have an “underweight” rating on the stock.
• 10/31/2026 – Baxter International was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/30/2026 – Baxter International was upgraded by Weiss Ratings from “sell (d-)” to “sell (d)”.
• 10/30/2026 – Baxter International had its price target lowered by JPMorgan Chase & Co. from $26.00 to $25.00. They now have a “neutral” rating on the stock.
• 10/30/2026 – Baxter International had its price target raised by Wells Fargo & Company from $23.00 to $25.00. They now have an “equal weight” rating on the stock.
• 10/29/2026 – Baxter International had its “hold” rating reaffirmed by Jefferies Financial Group. They now have a $25.00 price target on the stock.
• 10/20/2026 – Baxter International is now covered by Wolfe Research. They set a “peer perform” rating on the stock.
• 10/10/2026 – Baxter International was downgraded by Wall Street Zen from “buy” to “hold”.
• 10/8/2026 – Baxter International was downgraded by Weiss Ratings from “sell (d)” to “sell (d-)”.
• 10/7/2026 – Baxter International is now covered by Barclays. They set an “underweight” rating and a $20.00 price target on the stock.
• 10/5/2026 – Baxter International had its price target lowered by Citigroup from $28.00 to $27.00. They now have a “neutral” rating on the stock.

Baxter International Stock Performance

NYSE:BAX opened at $26.42 on Wednesday. The company has a market capitalization of $13.67 billion, a P/E ratio of -18.74, a P/E/G ratio of 3.89 and a beta of 0.68. The business has a fifty day simple moving average of $24.51 and a two-hundred day simple moving average of $21.57. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.79 and a quick ratio of 1.19. Baxter International Inc. has a 1 year low of $15.73 and a 1 year high of $30.00.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.06. The firm had revenue of $2.98 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.69 EPS. On average, analysts expect that Baxter International Inc. will post 2.10 earnings per share for the current year.

Baxter International Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be issued a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s dividend payout ratio is -2.84%.

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.